Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.4 SEK | -4.67% | -3.55% | +31.95% |
08/05 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
17/04 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.95% | 6.6Cr | |
+16.41% | 7.92TCr | |
+7.76% | 872.08Cr | |
-16.83% | 478.98Cr | |
+47.36% | 462.18Cr | |
+1.74% | 382.39Cr | |
+14.51% | 233.24Cr | |
-26.23% | 219.75Cr | |
+15.63% | 209.63Cr | |
-34.87% | 203.91Cr |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Orexo Hires New Chief Medical Officer